Credits Available: 4.5 AMA PRA Category 1 Credit™ & 4.5 MOC points, 4.5 ACPE

Description: Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in Western countries, with an age-adjusted incidence of 4.6 per 100,000 individuals per year. As small lymphocytic lymphoma (SLL) refers to the same malignant process with primary nodal involvement rather than blood, these are generally managed as a single condition (CLL/SLL). The selection of therapies for patients with relapsed/refractory CLL/SLL requires consideration of several factors including previous therapies, disease characteristics, and patient-specific factors such as co-morbidities and concurrent medications. Given the recency of new research into these targeted treatments and new approvals, clinicians lack background knowledge of the most current evidence and guideline recommendations in the treatment of CLL/SLL. Even within national guidelines, specific recommendations for initial treatment choice and sequencing are not directed. This collaborative social learning platform establishes a network of providers who can support each other locally, as well as those from different communities, with the goal of learning and sharing best practices that will improve outcomes for patients with relapsed/refractory chronic lymphocytic leukemia (CLL)/ small lymphocytic lymphoma (SLL).

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse, Nurse Practitioner, Physician Assistant
Target Specialties: Hematology, Hematology/Oncology, Oncology

Katherine Byar

Nebraska Medicine
Hematological Malignancy Nurse Practitioner

Katherine Byar, MSN, APRN-BC, BMTCN® is an malignant hematology/oncology nurse practitioner at the Fred and Pamela Buffett Cancer Center in Omaha, Nebraska.

Ms. Byar received her Master of Science in Nursing at the University of Nebraska Medical Center. She is certified as an Adult Nurse Practitioner and a Bone Marrow Transplant Certified Nurse.

With more than 30 years of experience and holding a variety of diverse roles in oncology, Katherine is recognized as a national nurse practitioner leader. She is currently working as an outpatient Advance Practice Provider responsible for the care of patients with hematological malignancies. Her clinical expertise includes hematologic malignancies, oncologic emergencies, CAR T-cell therapy, hematopoietic cell transplantation, survivorship, and supportive care. She is a prominent educator who has delivered hundreds of educational presentations to national and international audiences and authored numerous peer-reviewed publications, web courses, and book chapters. Ms. Byar co-edited the “ONS Cancer Basics third edition”. She also is an active member of the Oncology Nursing Society (ONS), and the Advanced Practitioner Society of Hematology and Oncology (APSHO).